holding shares of the Company Physical Holding Register/update the details in prescribed form ISR-1 and other relevant forms with Registrar and Transfer Agents of the Company, in physical form are invited to go through the said important communication under the weblink at https://india-pharma. ...
Pipeline growth through business development In October 2023, we announced an exclusive licence agreement with the Chinese company Hansoh Pharma for HS-20089, its B7-H4-targeted ADC. This supports our work in developing treatments for ovarian and endometrial cancers, as well as solid tumours. The ...
Luke as Head of the Pharma business and I talk quite often. Where it really makes sense, we want to go and capture some of the synergies because some of them exist there, but I wouldn't say it's core to our success in those markets. Steve Carty (AFC Advisers): Just to follow up...
Turning to performance of the Pharma business in the next slide. Overall, revenues grew 12%, driven by strong growth in new and specialty medicines, a prior year comparator that was impacted by destocking, and favorable US return and rebate adjustments in the quarter. Impact of prior destocking...